ReNeuron Group PLC
OTC:RNUGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
ReNeuron Group PLC
OTC:RNUGF
|
UK |
|
Vanguard Mining Corp
F:SL51
|
CA |
|
A
|
Anglo American PLC
DUS:NGLB
|
UK |
|
AroCell AB (publ)
F:80R
|
SE |
|
Granite Point Mortgage Trust Inc
F:G18
|
US |
|
K
|
Kitron ASA
XBER:KP5
|
NO |
|
Stora Enso Oyj
OTC:SEOJF
|
FI |
|
N
|
Nippon Steel Corp
SWB:NPS
|
JP |
|
E
|
Expo Gas Containers Ltd
BSE:526614
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RNUGF.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RNUGF Competitors Multiples
ReNeuron Group PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
R
|
ReNeuron Group PLC
OTC:RNUGF
|
1.9m USD | 7.7 | -0.4 | 0.5 | 0.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88.1 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.2 | 27.9 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44B EUR | 12.4 | 39.8 | 43.2 | 44.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |